Forty-two of the MLH1 variants were identified in patients diagnosed with colorectal cancer, eight with endometrial cancer, three with ovarian cancer, two with breast cancer, one with cervical cancer, and one with skin cancer (Table 4). Here, MLH1 is linked to endometrial cancer.